Products with Immunomodulators bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN6022 | Soyacerebroside I |
| 1. Soyacerebroside I demonstrates a potent tyrosinase inhibitory activity. 2. Soyacerebroside I shows anti-inflammatory activity, it can inhibit the accumulation of pro-inflammatory iNOS protein and reduce the expression of COX-2 protein in LPS-stimulated RAW264.7 macrophages. 3. Soyacerebrosides I and II have modulating the cellular immune response effects, they show obvious inhibitory activity on IL-18 secretion in human peripheral blood mononuclear cells (PBMC). | |
| BCN6029 | Soyacerebroside II |
| 1. Soyacerebroside II exhibits ionophoretic activity for Ca2+ ion. 2. Soyacerebrosides I and II have modulating the cellular immune response effects, they show obvious inhibitory activity on IL-18 secretion in human peripheral blood mononuclear cells (PBMC). | |
| BCN6059 | Syringin |
| Syringin (Eleutheroside B) has neuroprotective, tonic, adaptogenic, antitumour, anti- platelet aggregation, anti-inflammatory, antinociceptive ,and immune-modulating properties. It reduced the expression levels of inducible NO synthase (iNOS) ,COX,TNF-α, Beta Amyloid, and Caspase. | |
| BCN6160 | Paulownin |
| 1. (+)-Paulownin is active against the MCF-7 breast cancer cell line with IC50 values of 14.0 uM. 2. Paulownin has the action of anti-inflammation,analgesia,immunity,hypoglycemia and has little toxicity. 3. Paulownin demonstrates inhibitory activities against H. pylori Cystathionine gamma- synthase (HpCGS) with IC50 values of 19 +/- 2 microM, it can highly inhibit the growth of H. pylori and exhibit strong inhibitory specificity against H. pylori related to E. coli. | |
| BCN6261 | Yunaconitine |
| 1. Yunaconitine,extracted from several plants of Aconitum, has anti-inflammatory and analgesic actions. 2. Yunaconitine can increase serum total complement as well as the phag-ocytic activity of reticuloendothelial system in mice, these effects are considered to be beneficial in the clearance of pathogenic antigens, and may be the immunopharmacological basis of antiinflammatory actions of yunaconitine. | |
